Investigating the role of muscle myosin and shared pathogenetic mechanisms in neuromuscular disorders through in-depth single-fibre studies
Description of the granted funding
There is an increasing awareness in the clinical and scientific communities concerning the importance and need of a detailed understanding of muscle disorders, now being more efficiently diagnosed than before. Understanding the disease mechanisms is a pre-requisite for finding novel therapeutic options. In muscle disease patients, the day-to-day activities rapidly cause fatigue in the muscles, and recovery times are long. To date, no cure exists. The aim of our research group at the Folkhälsan Research Center is to shed light on the disease mechanisms, enabling us to connect the genetics to the clinical severity and course of the disease. We use novel single muscle-fibre methods, serving as a platform for finding new therapeutic targets and identifying patients who would benefit from a specific therapy. Our group is well connected for preparation of therapeutic trials, providing a possibility of direct implementation of therapies deemed to be safe and potentially efficient.
Show moreStarting year
2025
End year
2029
Funder
Research Council of Finland
Funding instrument
Academy research fellows
Decision maker
Scientific Council for Biosciences, Health and the Environment
16.06.2025
16.06.2025
Other information
Funding decision number
369939
Fields of science
Genetics, developmental biology, physiology
Research fields
Perinnöllisyystiede